drugset / Trial / NCT05918627
A Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male Subjects
RandomizedSequentialDouble-blindBasic science
Summary
The purpose of this study is to determine the safety, tolerability, and pharmacokinetics of multiple doses of SLx-2119 in healthy male participants.
Timeline
- Start
- 2009-09-21
- Primary completion
- 2009-12-09
- Completion
- 2009-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Belumosudil | Small molecule | 20 mg | Oral |
| Subject | Belumosudil | Small molecule | 40 mg | Oral |
| Subject | Belumosudil | Small molecule | 80 mg | Oral |
| Subject | Belumosudil | Small molecule | 160 mg | Oral |
| Subject | Belumosudil | Small molecule | 320 mg | Oral |
| Subject | Belumosudil | Small molecule | 640 mg | Oral |